Related Experiment Videos
Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading
K M Lally1, S Mocellin, G A Ohnmacht
1Department of Transfusion Medicine, Clinical Center, National Institute of Health, Bethesda, MD, USA.
Abstract:
The basis of intra-tumoral and systemic T cell reactivity toward cancer remains unclear. In particular the role that peripheral stimuli, whether endogenous or exogenous, play in shaping acquired immune response toward cancer remains poorly understood. In this study we document the surfacing of systemic immune reactivity toward a cryptic epitope from the MAGE-12 gene (MAGE-12:170-178), after temporary regression of a single melanoma metastasis, in response to gp100/PMel17-specific vaccination. This emergence was unlikely related to unusually high expression of MAGE-12 by the tumor, by the influence of analog epitopes to MAGE-12:170-178. Because MAGE-12 was unlikely to be expressed at sites other than the tumor, the demonstration of MAGE-12:170-178 reactivity in post- but not pre-vaccination circulating lymphocytes suggests that the systemically observed immune response was influenced by events induced by the vaccine at tumor site or draining lymph nodal areas. Possibly, as suggested by pre-clinical models, immunologic ignorance is the default response toward cancer in humans unless unusual stimulatory conditions occur in peripheral tissues. Surfacing of MAGE-12 specificity occurred in association with loss of gp100/PMel 17 targeted by the vaccine. This finding suggests that vaccinations might have effects beyond their intrinsic specificity and may trigger broader immune responses through epitope spreading by inducing changes within the tumor microenvironment. This may have important practical implication for the development of immunization strategies. Published 2001 Wiley-Liss, Inc.
Insights
Cancer vaccination can unexpectedly broaden immune responses. A melanoma vaccine triggered T cell reactivity to a new MAGE-12 epitope, suggesting epitope spreading and potential for enhanced cancer immunotherapy strategies.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- The mechanisms underlying anti-cancer T cell responses, both within tumors and systemically, are not fully understood.
- The influence of peripheral stimuli on acquired immune responses to cancer requires further investigation.
Purpose of the Study:
- To investigate the emergence of systemic immune reactivity to a cryptic epitope (MAGE-12:170-178) following melanoma metastasis regression after vaccination.
- To explore the role of peripheral stimuli and tumor microenvironment changes in shaping anti-cancer immunity.
Main Methods:
- Analysis of circulating lymphocytes before and after vaccination in a melanoma patient.
- Assessment of T cell reactivity to specific epitopes, including MAGE-12:170-178 and gp100/PMel17.
Main Results:
- Systemic T cell reactivity to the MAGE-12:170-178 epitope emerged post-vaccination, not pre-vaccination.
- This reactivity was observed after temporary regression of a melanoma metastasis in response to a gp100/PMel17-specific vaccine.
- MAGE-12 specificity surfaced concurrently with the loss of gp100/PMel17, suggesting broader immune activation.
Conclusions:
- Cancer vaccines may induce immune responses beyond their targeted antigens, potentially through epitope spreading.
- Changes within the tumor microenvironment, stimulated by vaccination, can influence systemic immune reactivity.
- These findings have implications for developing more effective cancer immunization strategies.